As blood cancers are constantly evolving and developing mutations that grow resistance to current treatments, researchers in ...

Researchers at Sutter's California Pacific Medical Center (CPMC) in San Francisco, Calif. have identified potential new ...

Generative artificial intelligence (AI) has absolutely exploded onto the scene. It's become a top strategic priority in the ...

Lead product candidate will be advanced to late IND-enabling studies to prepare for clinical trials for evaluation in the ...

This release is being retransmitted for extra exposure to downstream sites. SHELTON, CT / ACCESS Newswire / September 11, ...

Witness the mesmerizing journey of a sunflower's growth in our captivating time-lapse video, "Growing Sunflower Time-lapse Part 1: Seed to Day 30." This video captures every critical stage, showcasing ...

SHELTON, CONNECTICUT / ACCESS Newswire / September 9, 2025 / NanoViricides, Inc. (NYSE American:NNVC ) (the “Company”), a ...

Discover investment opportunities in Rezolute, Inc. as new drug ersodetug advances in phase 3 HI trials, with catalysts ...

(GLOBE NEWSWIRE) -- (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that an ...

Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) today announced the Company is in the process of addressing comments received by the U.S. Food and Drug Administration (FDA) in connection ...